<div id="readability-page-1">11:27 AM EST, 12/18/2025 (MT Newswires) -- Lixte Biotechnology ( LIXT ) said Thursday that it launched an approximately $4.3 million registered direct offering of common stock along with pre-funded and investor warrants at $4.09 per unit.The offering consisted of about 1.1 million units, each including one share of common stock or a pre-funded warrant, plus one common warrant to buy one common share per warrant, the company said.Net proceeds will be used for general corporate purposes and working capital, the company said.The offering is expected to close by Friday.Lixte Biotechnology ( LIXT ) shares were down over 2% in recent trading.Price: 3.87, Change: -0.09, Percent Change: -2.40 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

LIXT

Lixte Biotechnology 宣佈進行一項價值 430 萬美元的註冊直接發行普通股，包括以每單位 4.09 美元的價格預先融資和投資者認股權證。此次發行包括約 110 萬個單位，每個單位包含一股普通股或一個預先融資認股權證，以及一個普通認股權證。所得款項將用於一般企業用途和營運資金。此次發行預計將在週五之前完成。Lixte Biotechnology 的股票在最近的交易中下跌超過 2%

Lixte Biotechnology 啓動了價值 430 萬美元的註冊直接發行